CME Group (CME) Expected to Announce Earnings on Wednesday
by Doug Wharley · The Cerbat GemCME Group (NASDAQ:CME – Get Free Report) is expected to release its Q1 2026 results before the market opens on Wednesday, April 22nd. Analysts expect CME Group to post earnings of $3.11 per share and revenue of $1.7687 billion for the quarter. Parties can find conference call details on the company’s upcoming Q1 2026 earning report page for the latest details on the call scheduled for Wednesday, April 22, 2026 at 8:30 AM ET.
CME Group (NASDAQ:CME – Get Free Report) last announced its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share for the quarter, topping the consensus estimate of $2.75 by $0.02. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The business had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the prior year, the company earned $2.52 EPS. CME Group’s revenue for the quarter was up 8.1% on a year-over-year basis. On average, analysts expect CME Group to post $12 EPS for the current fiscal year and $13 EPS for the next fiscal year.
CME Group Price Performance
Shares of CME stock opened at $287.45 on Tuesday. The company has a quick ratio of 1.03, a current ratio of 1.03 and a debt-to-equity ratio of 0.12. CME Group has a twelve month low of $251.90 and a twelve month high of $329.16. The company has a market cap of $103.09 billion, a P/E ratio of 25.76, a P/E/G ratio of 2.94 and a beta of 0.26. The business has a fifty day simple moving average of $305.97 and a 200 day simple moving average of $285.78.
CME Group Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, March 26th. Investors of record on Tuesday, March 10th were given a dividend of $1.30 per share. The ex-dividend date was Tuesday, March 10th. This represents a $5.20 annualized dividend and a dividend yield of 1.8%. This is an increase from CME Group’s previous quarterly dividend of $1.25. CME Group’s dividend payout ratio is currently 46.59%.
Wall Street Analysts Forecast Growth
Several analysts recently weighed in on CME shares. Weiss Ratings upgraded CME Group from a “buy (b+)” rating to a “buy (a-)” rating in a research report on Monday, March 2nd. Argus restated a “hold” rating on shares of CME Group in a research report on Wednesday, March 4th. TD Cowen boosted their target price on shares of CME Group from $328.00 to $340.00 and gave the stock a “buy” rating in a research note on Thursday, April 9th. Royal Bank Of Canada boosted their target price on shares of CME Group from $295.00 to $302.00 and gave the stock a “sector perform” rating in a research note on Thursday, February 5th. Finally, Rothschild & Co Redburn decreased their target price on shares of CME Group from $347.00 to $340.00 and set a “neutral” rating on the stock in a research note on Monday, April 13th. Two research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $309.94.
Read Our Latest Research Report on CME
Insider Activity at CME Group
In other CME Group news, Director Martin J. Gepsman sold 300 shares of the business’s stock in a transaction on Friday, February 20th. The shares were sold at an average price of $305.90, for a total transaction of $91,770.00. Following the sale, the director owned 24,999 shares of the company’s stock, valued at approximately $7,647,194.10. The trade was a 1.19% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, General Counsel Jonathan L. Marcus sold 3,291 shares of the business’s stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the sale, the general counsel directly owned 7,192 shares in the company, valued at approximately $2,397,597.04. The trade was a 31.39% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 8,539 shares of company stock worth $2,713,821. Corporate insiders own 0.30% of the company’s stock.
Hedge Funds Weigh In On CME Group
A number of hedge funds have recently modified their holdings of the business. Rehmann Capital Advisory Group lifted its holdings in shares of CME Group by 4.3% during the third quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock worth $243,000 after purchasing an additional 37 shares during the period. CYBER HORNET ETFs LLC lifted its holdings in shares of CME Group by 4.3% during the third quarter. CYBER HORNET ETFs LLC now owns 975 shares of the financial services provider’s stock worth $263,000 after purchasing an additional 40 shares during the period. Integrated Advisors Network LLC lifted its holdings in shares of CME Group by 3.5% during the fourth quarter. Integrated Advisors Network LLC now owns 1,198 shares of the financial services provider’s stock worth $327,000 after purchasing an additional 40 shares during the period. F m Investments LLC lifted its holdings in shares of CME Group by 0.7% during the third quarter. F m Investments LLC now owns 5,565 shares of the financial services provider’s stock worth $1,504,000 after purchasing an additional 41 shares during the period. Finally, GeoWealth Management LLC lifted its holdings in shares of CME Group by 3.6% during the fourth quarter. GeoWealth Management LLC now owns 1,310 shares of the financial services provider’s stock worth $358,000 after purchasing an additional 46 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.
About CME Group
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.